FUBP1 and osteosarcoma: Moreover, we blocked AA metabolic pathway using a selective PTGES inhibitor CAY10526 in FUBP1‐overexpressing osteosarcoma cells and stimulated it using an EP2 receptor agonist Evatanepag in FUBP1‐silenced osteosarcoma cells.